Emerging Microbes & Infections

FIGURE 3

FROM:

Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library

Jie Feng, Ting Wang, Wanliang Shi, Shuo Zhang, David Sullivan, Paul G Auwaerter and Ying Zhang

BACK TO ARTICLE

Figure 3.

Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Representative images of stationary-phase B. burgdorferi strain B31 treated with different antibiotics (50 µM) followed by staining in the SYBR Green I/PI assay (×400 magnification). (A) Drug-free control, (B) Doxycycline, (C) Amoxicillin, (D) Daptomycin, (E) Cefoperazone, (F) Clofazimine, (G) Carbomycin, (H) Cefotiam, and (I) Tetracycline.

BACK TO ARTICLE